financetom
Business
financetom
/
Business
/
Stellantis set to secure Italian approval for Comau stake sale, says source
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stellantis set to secure Italian approval for Comau stake sale, says source
Oct 10, 2024 9:56 PM

ROME (Reuters) -Carmaker Stellantis is on course to secure Italian government backing for its planned sale of a majority stake in robotics business Comau to One Equity Partners, a source close to the matter said on Wednesday.

So-called golden power legislation gives the government the right to block or set conditions on deals concerning Italian companies that operate in strategic sectors.

Speaking on condition of anonymity, the source said the government was leaning towards conditional approval of the Comau transaction.

One Equity, which invests in businesses in the industrial, healthcare and technology industries in the United States and Europe, is expected to take a 50.1% stake in the company, with Stellantis retaining the remaining 49.9%, Reuters reported previously.

The deal has been criticised by Italian trade unions, which called on Prime Minister Giorgia Meloni's government to intervene.

A Comau spin-off from Stellantis was part of agreements between Fiat Chrysler and France's PSA, which merged in 2021 to create Stellantis, a Franco-Italian-US conglomerate which includes the Jeep, Peugeot, Fiat and Opel brands.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
(OFFICIAL)-UPDATE 3-US FDA approves Amgen drug for small cell lung cancer
(OFFICIAL)-UPDATE 3-US FDA approves Amgen drug for small cell lung cancer
May 17, 2024
(Amgen ( AMGN ) correction to pricing estimate in paragraph 4) May 16 (Reuters) - The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's ( AMGN ) tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung cancer that has worsened despite chemotherapy. The drug, marketed under the name Imdelltra, is...
Telefonica SA, H.I.G. Among Avatel Telecom's Suitors, Bloomberg Says
Telefonica SA, H.I.G. Among Avatel Telecom's Suitors, Bloomberg Says
May 17, 2024
01:46 PM EDT, 05/17/2024 (MT Newswires) -- Telefonica SA ( TEF ) and H.I.G. Capital are among the suitors considering bids for Spain's Avatel Telecom, Bloomberg reported Friday, citing people with knowledge of the matter. Price: 4.46, Change: +0.03, Percent Change: +0.68 ...
Salesforce First Quarter Likely Has Fewer Catalysts to be Excited About, Morgan Stanley Says
Salesforce First Quarter Likely Has Fewer Catalysts to be Excited About, Morgan Stanley Says
May 17, 2024
01:49 PM EDT, 05/17/2024 (MT Newswires) -- Salesforce ( CRM ) likely has fewer catalysts heading into fiscal first-quarter results despite stable demand, though the software maker appears to be in a solid position ahead of generative artificial intelligence product adoption in the medium term, Morgan Stanley said Friday. The company is scheduled to release first-quarter results May 29. Morgan...
Sector Update: Consumer
Sector Update: Consumer
May 17, 2024
01:34 PM EDT, 05/17/2024 (MT Newswires) -- Consumer stocks were mixed Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) decreasing 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) adding 0.2%. In corporate news, GameStop ( GME ) shares tumbled 25% after reporting preliminary results that pointed to a sharp year-over-year decline in fiscal Q1 sales,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved